
New Data Show Combination Antibody Treatment Reduces Risk of Death in Hospitalized COVID-19 Patients
The RECOVERY study demonstrated that an antibody combination therapy (REGEN-COV; Regeneron) improved survival in hospitalized patients, a first for COVID-19 antibody treatments.





























